InvestorsObserver
×
News Home

Where Does Aldeyra Therapeutics Inc (ALDX) Stock Fall in the Biotechnology Field After It Is Lower By -11.45% This Week?

Monday, April 24, 2023 03:32 PM | InvestorsObserver Analysts

Mentioned in this article

Where Does Aldeyra Therapeutics Inc (ALDX) Stock Fall in the Biotechnology Field After It Is Lower By -11.45% This Week?

Aldeyra Therapeutics Inc (ALDX) is around the top of the Biotechnology industry according to InvestorsObserver. ALDX received an overall rating of 87, which means that it scores higher than 87 percent of all stocks. Aldeyra Therapeutics Inc also achieved a score of 97 in the Biotechnology industry, putting it above 97 percent of Biotechnology stocks. Biotechnology is ranked 29 out of the 148 industries.

Overall Score - 87
ALDX has an Overall Score of 87. Find out what this means to you and get the rest of the rankings on ALDX!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Aldeyra Therapeutics Inc Stock Today?

Aldeyra Therapeutics Inc (ALDX) stock is lower by -8.18% while the S&P 500 has risen 0.02% as of 3:18 PM on Monday, Apr 24. ALDX is down -$0.82 from the previous closing price of $10.02 on volume of 1,728,897 shares. Over the past year the S&P 500 is down -3.77% while ALDX has risen 159.15%. ALDX lost -$1.06 per share the over the last 12 months. Click Here to get the full Stock Report for Aldeyra Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App